Trial · NCT04101331
Results by group30
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 30
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Overall Response Rate Assessed by Independent Review Committee Based on PET-CT | Cohort A | 32.4 | 95% Confidence Interval 23.7 to 42.1 | percentage | |
| Overall Response Rate Assessed by Investigator Based on PET-CT | Cohort A | 32.4 | 95% Confidence Interval 23.7 to 42.1 | percentage | |
| Overall Response Rate Assessed by Investigator Based on CT | Cohort A | 30.6 | 95% Confidence Interval 22.1 to 40.2 | percentage | |
| Complete Response Rate and Partial Response Rate Assessed by Independent Review Committee Based on PET-CT | Cohort A | Complete response rate (CR rate) | 12.0 | 95% Confidence Interval 6.6 to 19.7 | percentage |
| Complete Response Rate and Partial Response Rate Assessed by Independent Review Committee Based on PET-CT | Cohort A | Partial response rate (PR rate) | 20.4 | 95% Confidence Interval 13.2 to 29.2 | percentage |
| Complete Response Rate, Partial Response Rate and Overall Response Rate Assessed by Independent Review Committee Based on CT | Cohort A | Overall response rate (ORR) | 25.0 | 95% Confidence Interval 17.2 to 34.3 | percentage |
| Complete Response Rate, Partial Response Rate and Overall Response Rate Assessed by Independent Review Committee Based on CT | Cohort A | Complete response rate (CR rate) | 7.4 | 95% Confidence Interval 3.3 to 14.1 | percentage |
| Complete Response Rate, Partial Response Rate and Overall Response Rate Assessed by Independent Review Committee Based on CT | Cohort A | Partial response rate (PR rate) | 17.6 | 95% Confidence Interval 10.9 to 26.1 | percentage |
| Duration of Overall Response Assessed by Independent Review Committee Based on PET-CT | Cohort A | 2.3 | 95% Confidence Interval 1.9 to 8.7 | months | |
| Duration of Overall Response Assessed by Independent Review Committee Based on CT | Cohort A | 5.3 | 95% Confidence Interval 1.9 to 6.9 | months | |
| Duration of Overall Response Assessed by Investigator Based on PET-CT | Cohort A | 3.3 | 95% Confidence Interval 1.9 to 8.7 | months | |
| Duration of Overall Response Assessed by Investigator Based on CT | Cohort A | 6.3 | 95% Confidence Interval 2.0 to 8.7 | months | |
| Number of Subjects With Treatment Related Adverse Event | Cohort A | 105 | Participants | ||
| Maximum Measured Concentration (Cmax) of AFM13 | Cohort A | Cycle 1 - day 1 | 26232 | Geometric Coefficient of Variation 270 | Nanogram/milliliter |
| Maximum Measured Concentration (Cmax) of AFM13 | Cohort A | Cycle 1 - day 29 | 24435 | Geometric Coefficient of Variation 364 | Nanogram/milliliter |
| Area Under the Concentration-Time Curve of AFM13 From 0 to Infinity (AUC 0-∞) | Cohort A | Cycle 1 - day 1 | 612361 | Geometric Coefficient of Variation 60.3 | nanogram*hour/milliliter |
| Area Under the Concentration-Time Curve of AFM13 From 0 to Infinity (AUC 0-∞) | Cohort A | Cycle 1 - day 29 | 749717 | Geometric Coefficient of Variation 35 | nanogram*hour/milliliter |
| Volume of Distribution at Steady State (Vss) of AFM13 | Cohort A | 5.1 | Geometric Coefficient of Variation 58.4 | Liter | |
| The Terminal Half-life (t1/2) of AFM13 | Cohort A | Cycle 1 - day 1 | 20.7 | Geometric Coefficient of Variation 35.9 | hour |
| The Terminal Half-life (t1/2) of AFM13 | Cohort A | Cycle 1 - day 29 | 19.6 | Geometric Coefficient of Variation 47.4 | hour |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04101331/results